Background: Rotator cuff tears, a prevalent pathology with significant functional impact, primarily find their therapeutic approach in arthroscopic repair. The long-term success of this intervention is modulated by various factors, among which shoulder morphology stands out. In this context, the critical shoulder angle (CSA) has gained relevance as a potential predictor of postoperative prognosis. Objectives: To determine if the CSA influences the need for reoperation after retears and functional outcomes following the arthroscopic repair of chronic rotator cuff tears. Methods: A retrospective cohort study has been conducted, which includes 74 patients (between 47 and 86 years old, mean age of 58.85 ± 2.21 years) who underwent arthroscopic shoulder surgery for the repair of chronic rotator cuff tears by the traumatology service of a tertiary level hospital in the period between 2009 and 2022, to study variables such as the appearance of complications, reoperation, and functional outcomes. Results: Patients with a CSA greater than 40° represent 56.75% (n = 42). Functional improvement was achieved in 59.52%, in contrast to 40.48% of patients who did not obtain significant functional improvement (OR = 1.470; 95% CI = 1.009–2.141). The reoperation rate in this group was 21.4% (n = 9) (OR = 1.562; 95% CI = 1.085–2.249). Conclusions: This study provides statistically significant evidence that a high CSA (>40°) behaves as a risk factor for the reoperation rate and poorer functional outcomes after the arthroscopic repair of chronic rotator cuff tears.
Background/Objectives: Robotic-assisted total hip arthroplasty (raTHA) improves the accuracy and reproducibility of acetabular component positioning compared with conventional THA (cTHA), but whether this translates into superior patient-reported outcomes and satisfaction remains debated. Methods: A retrospective comparative cohort study was performed, including all patients who underwent primary raTHA with the Mako system at our institution (September 2024–May 2025) and an equal-sized control group recruited consecutively from an alphabetically ordered list of 172 eligible cTHAs, starting from a randomly selected letter (August 2022–January 2025), with a minimum follow-up of one year. Treatment allocation was determined by insurance coverage. The postoperative Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was the primary outcome; the Visual Analog Scale (VAS), modified Harris Hip Score (mHHS) and Forgotten Joint Score-12 (FJS-12) were secondary outcomes, and an overall satisfaction rating and willingness to undergo the surgery again were also recorded. Results: Ninety-three raTHA and 93 cTHA patients were analyzed. Follow-up was longer in the cTHA group (35.6 vs. 15.5 months; p < 0.001). Postoperative WOMAC (10.5 vs. 14.4; mean difference −3.8 points, 95% CI −7.4 to −0.2) and mHHS (86.9 vs. 84.7; mean difference 2.2 points, 95% CI −0.9 to 5.4) differed in rank-based comparisons, favoring raTHA (Mann–Whitney U test, p = 0.020 and p = 0.030, respectively). Point estimates were below the selected clinical-relevance thresholds, but the confidence intervals did not exclude clinically relevant differences; improvement from baseline did not differ between groups. There were no significant differences in VAS, FJS-12, overall satisfaction (9.32 vs. 9.31) or willingness to undergo surgery again (96.8% vs. 97.8%). Conclusions: Given insurance-based allocation, unequal follow-up and unadjusted analyses, robotic-assisted THA was associated with small differences in postoperative WOMAC and mHHS, whose point estimates were below the selected thresholds, although clinically relevant differences cannot be excluded; there were no differences in improvement, pain, joint awareness or satisfaction, which was very high in both groups. These findings do not establish a causal effect of robotic assistance; prospective randomized studies are needed.